0001209191-20-036491.txt : 20200612 0001209191-20-036491.hdr.sgml : 20200612 20200612214222 ACCESSION NUMBER: 0001209191-20-036491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200612 FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HALE DAVID F CENTRAL INDEX KEY: 0001024004 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36284 FILM NUMBER: 20961782 MAIL ADDRESS: STREET 1: 1042-B NORTH EL CAMINO REAL, SUITE 430 CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCEPT INC CENTRAL INDEX KEY: 0001044378 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 800943522 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5810 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-320-8200 MAIL ADDRESS: STREET 1: 5810 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-12 0 0001044378 BIOCEPT INC BIOC 0001024004 HALE DAVID F C/O BIOCEPT, INC. 5810 NANCY RIDGE DRIVE #150 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2020-06-12 4 S 0 159 0.5578 D 3477 I By LLC Common Stock 2020-06-12 4 S 0 445 0.5545 D 112 I By trust Common Stock 2020-06-12 4 S 0 556 0.555 D 867 D The sales reported herein were made for tax planning purposes. On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 105,463 fewer shares. On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 16,179 fewer shares. On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 41,295 fewer shares. /s/ Michael Nall, Attorney-in-Fact 2020-06-12